Joerg Petersen Selected Research

Joerg Petersen Research Topics

17	Infections 04/2023 - 01/2002
12	Chronic Hepatitis B 01/2020 - 09/2006
4	Fibrosis (Cirrhosis) 01/2020 - 05/2013
4	Viremia 02/2016 - 09/2007
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2016
3	Persistent Infection 10/2008 - 01/2005
2	Hepatitis B 01/2020 - 03/2008
2	Coinfection 01/2019 - 08/2015
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2014 - 07/2010
1	Fever (Fevers) 01/2020
1	Hepatitis C 01/2019
1	Reinfection 01/2018
1	Chronic Hepatitis C 02/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Inflammation (Inflammations) 08/2015
1	Liver Diseases (Liver Disease) 08/2015
1	Disease Progression 05/2013

9	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2005
6	Circular DNAIBA 03/2016 - 09/2006
4	NucleosidesIBA 01/2020 - 01/2012
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 09/2006
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2014 - 01/2005
3	NucleotidesIBA 01/2020 - 01/2012
3	Tenofovir (Viread)FDA Link 01/2020 - 01/2015
3	Hepatitis B e AntigensIBA 01/2020 - 09/2007
3	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 01/2002
2	AntigensIBA 01/2020 - 03/2014
2	entecavir FDA Link 01/2020 - 05/2013
2	VaccinesIBA 01/2020 - 01/2016
2	myrcludex-BIBA 01/2019 - 01/2018
2	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 02/2016
2	RNA (Ribonucleic Acid)IBA 01/2019 - 06/2011
2	Interferon-alpha (Interferon Alfa)IBA 03/2016 - 03/2014
2	InterferonsIBA 08/2015 - 06/2011
2	Plasminogen Activators (Plasminogen Activator)IBA 11/2014 - 01/2005
1	Reverse Transcriptase InhibitorsIBA 01/2020
1	ARC-520IBA 01/2020
1	sofosbuvir drug combination ledipasvirIBA 01/2019
1	SofosbuvirIBA 01/2019
1	velpatasvirIBA 01/2019
1	sodium-bile acid cotransporterIBA 01/2019
1	Hepatitis delta Antigens (HDAg)IBA 01/2019
1	nasIBA 03/2016
1	SimeprevirIBA 02/2016
1	daclatasvirIBA 02/2016
1	Viral ProteinsIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 03/2008
1	Peptides (Polypeptides)IBA 03/2008
1	adefovir dipivoxil (Hepsera)FDA Link 01/2008
1	Interferon-alpha2bIBA 01/2008
1	adefovirIBA 09/2006